Pearson I, Stevenson A, Krieger T, Ling C. What is the role of the company evidence submission in National Institute for Health and Care Excellence (NICE) multiple technology appraisals? Poster presented at the ISPOR 2019 European Conference; November 5, 2019. Copenhagen, Denmark. [abstract] Value Health. 2019 Dec; 22(S3).
Igarashi A, Kusel J, Pearson I, Ronquest N. Do innovative technologies require innovative appraisal techniques? - case studies from recent HTAs in the UK, US and Japan. Presented at the ISPOR 2019 European Conference; November 4, 2019. Copenhagen, Denmark.
Knight C, Pearson I. Economic modelling considerations for rare diseases. Presented at the ISPOR 2019 European Conference; November 4, 2019. Copenhagen, Denmark.
Robbins PB, Krieger T, Pearson I, Bell J, Doherty J. Use of TMB and PD-L1 to predict outcomes of checkpoint inhibitor treatment. Poster presented at the 2019 ASCO-SITC Clinical Immuno-Oncology Symposium; March 1, 2019. San Francisco, CA.